Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04025372
Title INTREPId (INTermediate Risk Erection PreservatIon Trial)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stamford Hospital Stamford Connecticut 06904 United States Details
Beth Israel Deaconness Medical Center Boston Massachusetts 02115 United States Details
Brigham and Women Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center Milford Massachusetts 01757 United States Details
Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital South Weymouth Massachusetts 02190 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63108 United States Details
XCancer Omaha / Urology Cancer Center Omaha Nebraska 68130 United States Details
NYU Long Island Garden City New York 11530 United States Details
NYU Langone Health New York New York 10016 United States Details
Associated Medical Professionals of NY Syracuse New York 13210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field